Based on the reported involvement of resistin in different cancers, particularly its role in acquired resistance, we hypothesized that resistin might be responsible for similar pro-oncogenic and chemoresistance-inducing functions in ovarian cancer cells as well. The gene discussed is RETN; the disease is ovarian carcinoma.